240 results on '"Choi, Woong Gil"'
Search Results
2. Effect of hemoglobin A1c change on 24-month clinical outcomes in patients with diabetes after acute myocardial infarction
3. Effect of delayed hospitalization on patients with non-ST-segment elevation myocardial infarction and complex lesions undergoing successful new-generation drug-eluting stents implantation
4. Influence of early dose reduction of ticagrelor on clinical outcomes following percutaneous coronary intervention for complex lesions
5. Efficacy and safety of cilostazol-based triple antiplatelet therapy compared with clopidogrel-based dual antiplatelet therapy in patients with acute ST-elevation myocardial infarction undergoing percutaneous coronary intervention: A multicenter, randomized, open-label, phase 4 trial
6. Immediate versus staged complete revascularization in patients with ST-segment elevation myocardial infarction and multivessel coronary artery disease: results from a prematurely discontinued randomized multicenter trial
7. Efficacy and safety of moderate-intensity statin with ezetimibe combination therapy in patients after percutaneous coronary intervention: a post-hoc analysis of the RACING trial
8. The angiography-guided spot versus entire stenting in patients with long coronary lesions trial: Study design and rationale for a randomized controlled trial protocol
9. Comparison between calcium channel blocker with angiotensin converting enzyme inhibitor or angiotensin II type 1 receptor blocker combination on the development of new-onset diabetes in hypertensive Korean patients
10. Clinical Impact of after-consult clinic blood pressure: comparison with automated office blood pressure
11. Impact of chronic outward force on arterial responses of proximal and distal of long superficial femoral artery stent
12. Early-Stage Vascular Response between Bare Metal Stent and Drug-Free Bioresorbable Vascular Scaffold in the Small-Sized Peripheral Artery: A Preclinical Study in Porcine Femoral Arteries
13. Impact of initial very low-level low-density lipoprotein cholesterol on the prognosis of acute myocardial infarction patients
14. Lower Atrial Fibrillation Risk With Sodium-Glucose Cotransporter 2 Inhibitors Than With Dipeptidyl Peptidase-4 Inhibitors in Individuals With Type 2 Diabetes: A Nationwide Cohort Study
15. 6-month versus 12-month or longer dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (SMART-DATE): a randomised, open-label, non-inferiority trial
16. Changes in alcohol consumption habits and risk of atrial fibrillation: a nationwide population-based study
17. Clinical Usefulness of PRECISE-DAPT Score for Predicting Bleeding Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: An Analysis From the SMART-DATE Randomized Trial
18. Comparative effect on platelet function of a fixed-dose aspirin and clopidogrel combination versus separate formulations in patients with coronary artery disease: A phase IV, multicenter, prospective, 4-week non-inferiority trial
19. Three-year major clinical outcomes of phosphorylcholine polymer- vs biolinx polymer-zotarolimus-eluting stents: A propensity score matching study
20. Changes in alcohol consumption habits and risk of atrial fibrillation: a nationwide population-based study.
21. Sex Differences in Delayed Hospitalization in Patients with Non-ST-Segment Elevation Myocardial Infarction Undergoing New-Generation Drug-Eluting Stent Implantation
22. Early Use of Low-dose Ticagrelor-based Dual Antiplatelet Therapy and Clinical Outcomes in Patients Undergoing Percutaneous Coronary Interventions for Complex Lesions
23. Long-term darapladib use does not affect coronary plaque composition assessed using multimodality intravascular imaging modalities: a randomized-controlled study
24. Moderate-Intensity Statin With Ezetimibe Combination Therapy vs High-Intensity Statin Monotherapy in Patients at Very High Risk of Atherosclerotic Cardiovascular Disease: A Post Hoc Analysis From the RACING Randomized Clinical Trial.
25. Secular trends and determinants of influenza vaccination uptake among patients with cardiovascular disease in Korea: Analysis using a nationwide database
26. Comparison of Antiplatelet Efficacy and Tolerability of Clopidogrel Napadisilate With Clopidogrel Bisulfate in Coronary Artery Disease Patients After Percutaneous Coronary Intervention: A Prospective, Multicenter, Randomized, Open-Label, Phase IV, Noninferiority Trial
27. Ambulatory blood pressure response to S‐amlodipine in Korean adult patients with uncontrolled essential hypertension: A prospective, observational study
28. Before Coronary CTO PCI: Burden or Location?
29. P2Y12 inhibitor monotherapy in complex percutaneous coronary intervention: A post-hoc analysis of SMART-CHOICE randomized clinical trial
30. Impact of initial very low-level low-density lipoprotein cholesterol on the prognosis of acute myocardial infarction patients
31. Stenting versus balloon angioplasty alone in patients with below-the-knee disease: A propensity score-matched analysis
32. Calcium channel blocker monotherapy versus combination with renin-angiotensin system inhibitors on the development of new-onset diabetes mellitus in hypertensive Korean patients
33. P2Y12 inhibitor monotherapy after coronary stenting according to type of P2Y12 inhibitor
34. Impact of genetic variants on clinical outcome after percutaneous coronary intervention in elderly patients
35. The effect of antiplatelet drug on coronary endothelial and microvascular function: comparison with ticagrelor and clopidogrel
36. Long-term Effects of P2Y12 Inhibitor Monotherapy After Percutaneous Coronary Intervention: 3-Year Follow-up of the SMART-CHOICE Randomized Clinical Trial
37. Safety of 3‐Month Dual Antiplatelet Therapy After Implantation of Ultrathin Sirolimus‐Eluting Stents With Biodegradable Polymer (Orsiro): Results From the SMART‐CHOICE Trial
38. Impact of Chronic Outward Force on Arterial Responses of Proximal and Distal of Long Superficial Femoral Artery Stent
39. Additional postdilatation using noncompliant balloons after everolimus‐eluting stent implantation: Results of the PRESS trial
40. Effects of Early Losartan Therapy on Ventricular Late Potentials in Acute Myocardial Infarction
41. Safety and Efficacy of a New Ultrathin Sirolimus-Eluting Stent with Abluminal Biodegradable Polymer in Real-World Practice
42. 6-month versus 12-month or longer dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (SMART-DATE): a randomised, open-label, non-inferiority trial
43. Long-Term Sirolimus for Primary Immunosuppression in Heart Transplant Recipients
44. The Impact of Prediabetes on Two-Year Clinical Outcomes in Patients Undergoing Elective Percutaneous Coronary Intervention
45. SIROLIMUS-BASED IMMUNOSUPPRESSION MITIGATES PROGRESSION OF CARDIAC ALLOGRAFT VASCULOPATHY AND IMPROVES CARDIAC OUTCOMES AFTER HEART TRANSPLANTATION: A SINGLE CENTER 15-YEAR FOLLOW-UP STUDY
46. Long-term darapladib use does not affect coronary plaque composition assessed using multimodality intravascular imaging modalities: a randomized-controlled study.
47. Impact of Cigarette Smoking: a 3-Year Clinical Outcome of Vasospastic Angina Patients
48. CRT-169 Impact Of Chronic Alcohol Consumption On 5-year Clinical Outcomes in Patients with Significant Coronary Artery Spasm; A Propensity Score Matching Study
49. CRT-602 Impact Of High Lipoprotein(a) Levels On 5-year Clinical Outcomes Following Percutaneous Coronary Intervention With Drug-eluting Stent In Asian Population
50. CRT-309 Impact of Duration of Statin Medication on Clinical Outcomes in Patients Undergoing Percutaneous Transluminal Angioplasty for Atherosclerotic Peripheral Arterial Disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.